Indus Biotech awaits DCGI clearance for its botanical H1N1 drug to start trials

Indus Biotech is awaiting clearance from the Drugs Controller General of India for its H1N1 drug that is ready for clinical trials. The company has submitted IND (Investigational New Drug) dossiers in September.

The details can be read here.